TAKE
TAKE stock
TAKE is showing a constructive news setup around Broad_market, with 40 recent stories and improving sentiment breadth.
TAKE stock
TAKE is showing a constructive news setup around Broad_market, with 40 recent stories and improving sentiment breadth.
TAKE has built a constructive coverage cluster in the last 4 days. The strongest recurring theme is Broad_market, while the current weighted impact score is +34 from 13 bullish, 2 bearish, and 16 neutral stories across 5 sources.
TAKE is last saved at ₹20.74 with a day move of +0.00%. That quote should be read with the article tape: a positive headline only matters if price, volume, and follow-through confirm it; a negative headline matters more when it keeps repeating across multiple publishers.
Quarterly filing context will appear here after the saved-results sync has enough extracted fields. This hub keeps the permanent stock view separate from short-lived article pages, so search engines and users get one accumulated view instead of scattered programmatic summaries.
Economic Times · 8 hr ago · 2 min read
Mint · 9 hr ago · 2 min read
Economic Times · 9 hr ago · 2 min read
Economic Times · 10 hr ago · 2 min read
Mint · 10 hr ago · 2 min read
How TAKE stacks against related names in this news cluster
TAKE has appeared across 40 recent stories from 5 sources, which usually means there is a real flow of fresh headlines rather than a single isolated mention.
TAKE coverage is currently leaning bullish, with 13 bullish, 2 bearish, and 16 neutral analyzed stories in the recent window.
Recent TAKE coverage is clustering around Broad_market and Banking. Related names showing up alongside TAKE include RELIANCE, PCJEWELLER, SBIN.
Use this page as a coverage hub for TAKE: start with the latest headlines, then check the dominant themes, related names, and saved market context before you form a trade or watchlist view.
6 recent mentions linked to TAKE
TopicBanking4 recent mentions linked to TAKE
StockRELIANCERelated news cluster with 3 links
Latest storyBullish for MANKIND: Pharma Major Divests Hospitality Arm for Rs 49 CrThe Indian pharma sector is currently focused on core competencies, product pipelines, and regulator